Socioeconomic disparities in clinical trials on Alzheimer's disease: a systematic review.
Marco CanevelliG BrunoC VicoV ZaccariaE LacorteI IavicoliN VanacoreM CesariPublished in: European journal of neurology (2018)
The research and clinical relevance of SES has mistakenly been overlooked by the vast majority of RCTs on AD. A greater effort should be made to collect and report data on those SES indicators that may significantly affect the clinical manifestations and trajectories of patients with cognitive disturbances.